Where Do Get It? – Here – Lucky Prizemoney for NSW Trot Races and Group 1’s is Good

Description

Ziconotide is an N-type calcium channel antagonist used to manage patients with severe chronic pain who cannot tolerate, or who have not responded adequately to other treatments such as intrathecal morphine and systemic analgesics . It is a neurotoxic peptide derived from the cone snail Conus magus comprising 25 amino acids with three disulphide bonds .

Molecular Structure Analysis

Ziconotide has a molecular formula of C102H172N36O32S7 . It has an average mass of 2639.134 Da and a monoisotopic mass of 2637.098389 Da . The molecule contains a total of 352 bonds, including 180 non-H bonds, 34 multiple bonds, 40 rotatable bonds, 28 double bonds, and 6 aromatic bonds .

Chemical Reactions Analysis

Ziconotide is a selective N-type voltage-gated calcium channel blocker . This action inhibits the release of pro-nociceptive neurochemicals like glutamate, calcitonin gene-related peptide (CGRP), and substance P in the brain and spinal cord, resulting in pain relief .

Physical And Chemical Properties Analysis

Ziconotide is a solid compound . It is soluble in water (100 mg/mL) and DMSO (25 mg/mL) when ultrasonicated . It should be stored at ≤ -20°C, protected from light, dry, and sealed .

Scientific Research Applications

Subscribe or log in to read the rest of this content.
The articles published on this site are the honestly held opinion of the author, based on observation, research and the materials available to and read or watched by them. The author makes no representation that the opinions expressed are strictly factual or provable in law. Racing is funded by public money, and issues to do with racing and gambling are matters of public interest. The honestly held opinions expressed in articles on the site are published on the basis of the public interest in the integrity of racing. Should any person believe that the author's opinions expressed herein are incorrect we encourage them to contact the author at peterprofitracing@gmail.com with their concerns, and appropriate corrections, alteration and deletions where appropriate will be made.
error: Content is protected !!